Need professional-grade analysis? Visit stockanalysis.com
$11.85B
16.68
N/A
3.04%
Zhejiang CONBA Pharmaceutical Co Ltd (600572) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY4.68, down 5.26% from the previous close.
Over the past year, 600572 has traded between a low of CNY4.20 and a high of CNY4.94. The stock has gained 5.2% over this period. It is currently 5.3% below its 52-week high.
Zhejiang CONBA Pharmaceutical Co Ltd has a market capitalization of $11.85B, with a price-to-earnings ratio of 16.68 and a dividend yield of 3.04%.
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.
Side-by-side comparison against top Healthcare peers.